In this article for the Children’s Health Defense, Dr. James Lyons-Weiler and Robert F. Kennedy, Jr. takes an in-depth look at the Briefing document on the Pfizer-BioNTech COVID-19 vaccine which was released by the Vaccines and Related Biological Products Advisory Committee of the Food and Drugs Administration (FDA). 

The authors say that there are a number of issues in the vaccine trial results. Many of these issues were easy to overlook: the definition of serious vs. non-serious adverse events, and the design analysis set-up of the study which is biased against finding adverse effects. The results cited by Dr. Lyons-Weiler and Kennedy show the side effects of the vaccine and the high probability of pathogenic priming, a concern that has arisen in the development of SARS-CoV-1 and MERS vaccines.

Read the original briefing document on the FDA website. 

Editor’s Note: The reason why there are no SARS-CoV-1 and MERS vaccines today is due to disease enhancement where vaccinated individuals tend to develop severe complications when challenged with the wild strain of the viruses [this could also be the reason for the confusing results of the Oxford-AstraZeneca vaccine trials, see Oxford-AstraZeneca vaccine delivers confusing results]. How sure are we that such will not happen with the SARS-CoV-2 vaccines? The truth is, even with mRNA technology, we can’t. There is simply not enough data to support the claim that these vaccines are effective and safe [a new petition has been started in the UK seeking to suspend all clinical trials of COVID-19 vaccines, see Petition against Pfizer and other coronavirus vaccines launched in the UK]. In fact, if we base on the results of earlier trials, we know that these vaccines are dangerous [see A touted COVID-19 vaccine has already harmed people].

Read Original Article